{"id":305098,"date":"2018-12-17T00:21:04","date_gmt":"2018-12-17T00:21:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=305098"},"modified":"2018-12-17T00:21:04","modified_gmt":"2018-12-17T00:21:04","slug":"biologics-safety-testing-market-by-scope-for-gene-therapy-progressing-drugs-and-diagnosis-research-report-2018-technological-growth-and-demand-prospects","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biologics-safety-testing-market-by-scope-for-gene-therapy-progressing-drugs-and-diagnosis-research-report-2018-technological-growth-and-demand-prospects_305098.html","title":{"rendered":"Biologics Safety Testing Market by Scope for Gene Therapy, Progressing Drugs and Diagnosis Research Report 2018 | Technological Growth and Demand Prospects"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Biologics Safety Testing Market”<\/div>\n<\/div>\n<\/div>\n
Biologics Safety Testing Market to Grow 13.6% CAGR during the Forecast Period 2018 to 2023<\/div>\n

Global Biologics Safety Testing Market is expected to grow significantly over the forecast period. The market held a market value of USD 2.79 billion in 2017 and is projected to register a CAGR of 13.6% over the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure that the product is safe and free of contaminants. Recently, CDER approved 46 novel drugs in 2017, whereas 22 in 2016.<\/p>\n

Key Players:<\/strong><\/p>\n

Some of the prominent players in the global biologics safety testing market are Merck KGaA, Charles River Laboratories, Sartorius AG, Lonza Group Ltd., SGS S.A., Thermo Fisher Scientific Inc, Wuxi Apptec, Cytovance Biologics, Inc., Avance Biosciences Inc., and Eurofins Scientific.<\/p>\n

Get Sample Research Report at https:\/\/www.marketresearchfuture.com\/sample_request\/6800<\/a><\/strong><\/p>\n

Regional Analysis:<\/strong><\/p>\n

Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and rising demand for biological products. Europe is expected to hold the second largest position in the global market owing to the growing pharma and biotech industry. Asia-Pacific is expected to be the fastest growing market owing to the increasing demand for biologics products. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global market.<\/p>\n

Segmentation:<\/strong><\/p>\n

The global biologics safety testing market has been segmented into product, test type, and application.<\/p>\n

Based on product, the market is segmented into kits and reagents, services, and instruments. The kits and reagents segment accounted for the largest share of the market in 2017.<\/p>\n

Based on test type, the market is segmented into sterility tests, endotoxin tests, cell line authentication and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and others.<\/p>\n

Based on application, the market is segmented into vaccine and therapeutics development, blood and blood-related products testing, cellular and gene therapy, tissue and tissue-related products testing, and stem cell research.<\/p>\n

Intended Audience<\/strong><\/p>\n